Managing Complicated Patients with T2D
Upon completion of this activity, participants will:
- Demonstrate improved performance associated with:
- Ordering and interpreting tests used to diagnose CKD and monitor progression in patients with T2D
- Individualizing management of patients with T2D and CKD to improve patient outcomes and prevent progression to ESRD
George L. Bakris, MD
Professor of Medicine
Director, AHA Comprehensive Hypertension Center
The University of Chicago Medicine, Chicago, Illinois
Carol H. Wysham, MD
Clinical Associate Professor of Medicine
University of Washington-School of Medicine
Section Head, Rockwood Center for Diabetes and Endocrinology
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.